Greater Glasgow and Clyde Medicines

Information below is specific to the use of medicines in the adult setting PPIs and hypomagnesaemia In April 2012 the MHRA issued advice about the risk of hypomagnesaemia with long term proton pump inhibitor (PP...

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on 11th August 2014. The Formulary decisions from that meeting are summarised in this post

Acute Kidney Injury (AKI) and Prescribing AKI is common in hospitalised patients with intercurrent illness, multiple co-morbidities and polypharmacy.  It is defined as a sudden and sustained decline in Glo...

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on 9^th June. The Formulary decisions from that meeting are summarised in this post

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on 28th April. The Formulary decisions from that meeting are summarised in this post

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met in February 2014. The Formulary decisions from that meeting are summarised in this post

In this issue:

• Antiepileptic drugs and brand prescribing
• TrakCare discharge prescriptions: What do pharmacists check?
• Gentamicin and vancomycin online dose calculators: care with data entry
• Emergency Care Summary (ECS): an update
• Guideline news

Information included is specific to the use of medicines in the adult setting.

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met in December 2013. The Formulary decisions from that meeting are summarised in this post.

Pharmacological management of adult patients with type 2 diabetes

Withdrawn as more than 2 years old and content no longer valid.  

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met in October 2013. The Formulary decisions from that meeting are summarised in this post.